CS logo
small CS logo
Kinderspital Zürich

Zurich, Switzerland
Children's hospital
Steinwiesstrasse 75, 8032 Zürich

About Kinderspital Zürich


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Vertex Pharmaceuticals Incorporated
8
AO Clinical Investigation and Publishing Documentation
2
Boehringer Ingelheim
2
Celgene
2
Eisai Inc.
2
Fondazione Epatocentro Ticino
2
University Children's Hospital Basel
2
University Children's Hospital, Zurich
2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1
Baxalta now part of Shire
1
Bayer
1
Total Rows: 28

Clinical Trials at Kinderspital Zürich


During the past decade, Kinderspital Zürich conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 9 clinical trials were completed, i.e. on average, 28.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66114499333355110000001100331144Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Retrospective Eight Plate Study
2012-07-01
2013-12-01
Completed
138
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
2013-04-01
2016-11-01
Withdrawn
0
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
2013-04-18
2031-04-01
Active, not recruiting
102
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
2013-09-25
2019-11-14
Completed
267
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
2013-04-01
2026-04-01
Recruiting
1,000
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
2013-12-04
2018-11-06
Completed
107
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
2011-06-29
2024-01-16
Active, not recruiting
956
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
2014-09-29
2019-11-19
Completed
214

Rows per page:

1–42 of 42

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kinderspital Zürich" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 8 trials, followed by "AO Clinical Investigation and Publishing Documentation" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kinderspital Zürich" #1 collaborator was "ALL SCTped Forum" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Luzerner Kantonsspital" with 2 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Kinderspital Zürich


According to Clinical.Site data, the most researched conditions in "Kinderspital Zürich" are "Cystic Fibrosis" (8 trials), "Neuroblastoma" (2 trials), "Rhabdomyosarcoma" (2 trials), "Venous Thromboembolism" (2 trials) and "AB Variant Gangliosidosis GM2" (1 trials). Many other conditions were trialed in "Kinderspital Zürich" in a lesser frequency.

Clinical Trials Intervention Types at Kinderspital Zürich


Most popular intervention types in "Kinderspital Zürich" are "Drug" (26 trials), "Other" (6 trials), "Device" (3 trials), "Genetic" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "IVA" (8 trials), "ELX/TEZ/IVA" (5 trials), "Cyclophosphamide" (3 trials), "Ifosfamide" (3 trials) and "Placebo (matched to ELX/TEZ/IVA)" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Kinderspital Zürich


The vast majority of trials in "Kinderspital Zürich" are 42 trials for "All" genders.

Clinical Trials Status at Kinderspital Zürich


Currently, there are 22 active trials in "Kinderspital Zürich". 1 are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Kinderspital Zürich, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kinderspital Zürich, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status